

ADVANCING BIOTECH ENTREPRENEURSHIP
​
CEBINA uniquely supports life science entrepreneurs and early-stage start-up companies and develops cutting-edge biotech projects
ABOUT US
CEBINA was founded with the aim of creating, nurturing, and promoting early-stage life sciences companies, to develop new medicines and cutting-edge technologies.
With decades-long experience in pharmaceutical product development and biotech entrepreneurship, our team supports our internal projects and resident companies with cutting edge facilities and tailor-made services throughout all stages of company development.
For each new project, CEBINA undertakes extensive due diligence to identify projects with the highest potential, offering attractive, de-risked opportunities for investors.

17 February 2021
URSAPHARM Arzneimittel and CEBINA announce partnership to repurpose the antihistamine azelastine to combat COVID-19
Read more

19 November 2020
Eveliqure announces the publication of key preclinical data for its clinical stage vaccine candidate against Shigellosis and ETEC
Read more

24 September 2020